Inborn error in the terminal step of aldosterone biosynthesis. Corticosterone methyl oxidase tpe II deficiency in a North American pedigree

The New England Journal of Medicine
J D VeldhuisJ C Melby

Abstract

Profound salt wasting developed in a male infant who had marked reductions in serum and urinary aldosterone concentrations despite striking hyperreninemia. Coincident elevations in plasma and urinary levels of specific 18-hydroxysteroids localized the defect to corticosterone methyl oxidase Type II, the adrenal enzyme responsible for the final step of aldosterone synthesis. Salt replacement but not hydrocortisone ameliorated the clinical and metabolic abnormalities. Evaluation of 33 other family members disclosed the biochemical disorder in six other subjects who were affected in an autosomal-recessive pattern with variably severe clinical manifestations and abnormal ratios of 18-hydroxycorticosterone (or its metabolites) to aldosterone. This inborn error in aldosterone biosynthesis must be distinguished from other heritable, salt-losing defects in adrenal steroidogenesis.

References

Jul 1, 1976·The Journal of Clinical Investigation·G H WilliamsR H Underwood
Oct 1, 1976·The Journal of Clinical Endocrinology and Metabolism·S L DaleJ C Melby
Feb 1, 1977·The Journal of Clinical Endocrinology and Metabolism·A RöslerD Rabinowitz
Sep 1, 1977·The Journal of Clinical Endocrinology and Metabolism·A RöslerM I New
Jan 1, 1979·Hormone Research·D KatznelsonB Lunenfeld
Oct 1, 1978·The Journal of Clinical Endocrinology and Metabolism·R J AgrinJ C Melby
Jun 1, 1977·Journal of Steroid Biochemistry·J H PrattJ C Melby
Feb 1, 1977·The Journal of Clinical Endocrinology and Metabolism·A RöslerS Ulick
Jul 1, 1977·Archives of Disease in Childhood·P J MillaC Shackleton
Jul 1, 1976·The Journal of Clinical Endocrinology and Metabolism·S Ulick
Aug 1, 1976·Archives of Disease in Childhood·W HamiltonC E Gray
Mar 1, 1975·The Journal of Clinical Endocrinology and Metabolism·J SassardJ F Cier
Dec 1, 1966·The Journal of Clinical Investigation·E G BiglieriN Brust
Apr 1, 1972·Kidney International·J E SealeyJ H Laragh
Mar 1, 1974·The Journal of Clinical Endocrinology and Metabolism·A KowarskiC J Migeon
Oct 1, 1972·The Journal of Clinical Endocrinology and Metabolism·R R DavidW D Drucker
Mar 1, 1966·The Journal of Clinical Investigation·M I NewR E Peterson
Oct 1, 1958·The Journal of Clinical Investigation·M B LIPSETT, O H PEARSON
Nov 1, 1962·The Journal of Clinical Investigation·A M BONGIOVANNI
Jul 1, 1964·The Journal of Clinical Endocrinology and Metabolism·S ULICKC U LOWE
Oct 1, 1964·The Journal of Physiology·J J BROWNJ I ROBERTSON
Jun 1, 1965·The Journal of Clinical Investigation·G T BRYANF C BARTTER

❮ Previous
Next ❯

Citations

May 1, 1988·Indian Journal of Pediatrics·B E Booth
Dec 1, 1982·Irish Journal of Medical Science·R O'Kelly, T J McKenna
Jan 1, 1995·Steroids·Y ShizutaH Imura
Dec 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·P C WhiteA Rösler
May 12, 2004·Molecular and Cellular Endocrinology·Perrin C White
Dec 29, 1983·The New England Journal of Medicine·F A WilliamsR M Carey
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M P Malee, S H Mellon
Jun 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·L PascoeP C White
Mar 1, 1996·Pediatric Research·M Peter, W G Sippell
Nov 6, 2010·Endocrine Reviews·Walter L Miller, Richard J Auchus
Nov 1, 1985·Clinics in Endocrinology and Metabolism·J C Melby
Mar 1, 1982·Clinics in Endocrinology and Metabolism·I A Hughes
Jul 1, 1984·Clinics in Endocrinology and Metabolism·R Fraser
Jan 1, 1983·The Journal of Pediatrics·J D VeldhuisJ C Melby
Jan 1, 1984·Journal of Receptor Research·E J Ariëns
Nov 1, 1983·Anaesthesia and Intensive Care·G S Stokes
Aug 16, 1984·Klinische Wochenschrift·D KlausP Vecsei
Jul 1, 1995·Journal of Endocrinological Investigation·L Pascoe
Aug 1, 1992·Trends in Endocrinology and Metabolism : TEM·P C White, L Pascoe
Oct 1, 1981·Clinical Biochemistry·M I New, L S Levine
Jul 1, 1987·The Journal of Pediatrics·W L Miller, L S Levine
Nov 1, 1985·Clinics in Endocrinology and Metabolism·C W Burke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.